A Phase 2 Study of KPT-330 in Metastatic Castrate Resistant Prostate Adenocarcinoma

Trial Profile

A Phase 2 Study of KPT-330 in Metastatic Castrate Resistant Prostate Adenocarcinoma

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 14 Jan 2014

At a glance

  • Drugs Selinexor (Primary)
  • Indications Bone metastases; Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top